Northwestern University Human Resources

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1851-01-28

Employees: 5K

Market Cap: -

Website: https://www.venturecat.northwestern.edu

Clinical Trials

NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery

Early Phase 1

Completed

Conditions: Gliosarcoma
Recurrent Glioblastoma

Interventions: Other: Laboratory Biomarker Analysis
Other: Pharmacological Study
Drug: Targeted Molecular Therapy

First Posted Date: 2017-01-13

Last Posted Date: 2022-08-26

Lead Sponsor: Northwestern University

Target Recruit Count: 8

Registration Number: NCT03020017

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

Phase 4

Conditions: Castration-Resistant Prostatic Cancer
Stage IV Prostate Cancer
Hormone-Refractory Prostate Cancer
Recurrent Prostate Carcinoma
Metastatic Prostate Carcinoma

Interventions: Biological: GnRH agonist/antagonist
Drug: Enzalutamide
Drug: Prednisone
Drug: Abiraterone Acetate

First Posted Date: 2017-01-11

Last Posted Date: 2021-05-03

Lead Sponsor: Northwestern University

Target Recruit Count: 100

Registration Number: NCT03016741

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
University of Minnesota: Masonic Cancer Center, Minneapolis, Minnesota, United States

and more 1 locations

Treating Verbal Memory Deficits Following Chemotherapy for Breast Cancer

Not Applicable

Completed

Conditions: Breast Cancer Treatment
Cognitive Deficits

Interventions: Behavioral: Computerized cognitive treatment

First Posted Date: 2017-01-11

Last Posted Date: 2023-11-07

Lead Sponsor: Northwestern University

Target Recruit Count: 45

Registration Number: NCT03017560

Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects

Phase 2

Active, not recruiting

Conditions: Prostate Cancer Metastatic Castration-Resistant
Metastatic Prostate Carcinoma
Abnormal DNA Repair
Stage IV Prostate Cancer

Interventions: Drug: Olaparib
Drug: Abiraterone Acetate
Drug: Prednisone

First Posted Date: 2017-01-06

Last Posted Date: 2023-08-30

Lead Sponsor: Northwestern University

Target Recruit Count: 70

Registration Number: NCT03012321

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States
🇺🇸
University of Virginia, Charlottesville, Virginia, United States
🇺🇸
Northwestern Medicine, Chicago, Illinois, United States

and more 15 locations

The Effects of Video Modeling of Audiological Testing on Pediatric Patient Compliance

Phase 1

Completed

Conditions: Autism

Interventions: Behavioral: Video Modeling Intervention
Behavioral: Placebo Video

First Posted Date: 2016-12-23

Last Posted Date: 2018-08-21

Lead Sponsor: Northwestern University

Target Recruit Count: 20

Registration Number: NCT03002363

Locations: 🇺🇸
Northwestern Clinic for Audiology, Speech, Language, and Learning, Evanston, Illinois, United States

SMART Weight Loss Management

Not Applicable

Completed

Conditions: Weight Loss

First Posted Date: 2016-12-20

Last Posted Date: 2021-05-18

Lead Sponsor: Northwestern University

Target Recruit Count: 400

Registration Number: NCT02997943

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

A Prospective Study of Breast Cancer Patients With Abnormal Strain Imaging

Phase 2

Active, not recruiting

Conditions: HER2 Positive Breast Cancer
Cardiovascular Abnormalities

Interventions: Drug: Carvedilol

First Posted Date: 2016-12-15

Last Posted Date: 2024-06-03

Lead Sponsor: Northwestern University

Target Recruit Count: 134

Registration Number: NCT02993198

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

txt2protect: Using Text Messaging to Increase HPV Vaccination Among Young Sexual Minority Men

Not Applicable

Completed

Conditions: Human Papillomavirus

Interventions: Behavioral: txt2protect
Behavioral: Sexual Health Control

First Posted Date: 2016-12-15

Last Posted Date: 2020-07-20

Lead Sponsor: Northwestern University

Target Recruit Count: 150

Registration Number: NCT02994108

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast

Phase 2

Completed

Conditions: Estrogen Receptor Positive
Ductal Breast Carcinoma In Situ

Interventions: Other: Laboratory Biomarker Analysis
Drug: Afimoxifene
Drug: Tamoxifen Citrate
Other: Placebo

First Posted Date: 2016-12-15

Last Posted Date: 2024-12-18

Lead Sponsor: Northwestern University

Target Recruit Count: 100

Registration Number: NCT02993159

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
Saint Elizabeth Medical Center South, Edgewood, Kentucky, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

and more 3 locations

Measuring Patient Engagement in Diabetes Care

Withdrawn

Conditions: Diabetes Mellitus, Type II

First Posted Date: 2016-12-09

Last Posted Date: 2017-03-15

Lead Sponsor: Northwestern University

Registration Number: NCT02988427

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy